Pure Global AI
Swedish Medical Products Agency · Europe

Sweden medical device regulatory resources

Every Sweden dataset, comparison, and AI workpaper we maintain — one entry point for the whole market.

5 free resources23/25 topics with recordsAug 2026 fees reviewed
Run the classification agent

Everything we track for Sweden

Medical device regulation news

Follow recent Swedish Medical Products Agency policy, guidance, safety, and compliance updates.

AI medical device classifier

Describe your device and get a preliminary MPA risk class with official rule references.

Government registration fees

Review current Swedish Medical Products Agency application, review, and renewal fees.

Additional certification and licence checker

Check whether product features may trigger separate radio, electrical, metrology, radiation, import, or other Sweden requirements.

Registration timeline

Compare the statutory notified-body conformity assessment clock under Regulation (EU) 2026/977 with realistic CE marking times by device class.

Changes after registration

Explore questions and sources →

Common questions about changing a registered medical device in Sweden. Each question separates published rules from details still awaiting verification.

Structured regulatory requirements

Explore all 50 source-linked facts →

23 of 25 research dimensions currently covered · 39 official sources · latest verification 2026-10-21

Market entry

D01

Authority & regime

Verified
Competent authority
Läkemedelsverket (Swedish Medical Products Agency) is the Swedish competent authority for medical devices and IVDs under MDR/IVDR, responsible for market control and supervision of actors t…
Supervision split for healthcare use
Läkemedelsverket holds supervision over compliance with MDR/IVDR, with a carve out in 5 kap. 2 § förordning (2021:631) placing certain supervision concerning health and medical care activit…
2 source-linked facts
Checked 2026-08-25
Open details →
D02

Legal basis & guidance

Verified
Interim national reporting rules until Eudamed is functional
Until Eudamed is fully functional, complementary national requirements on how serious incident and FSCA reporting to Läkemedelsverket must be made are set in Läkemedelsverkets föreskrifter…
National legal framework complementing MDR/IVDR
Sweden's national framework complementing MDR and IVDR: Lag (2021:600) med kompletterande bestämmelser till EU:s förordningar om medicintekniska produkter and förordning (2021:631), in forc…
2 source-linked facts
Checked 2026-08-25
Open details →
D03

Device definition & scope

Verified
National category: national medical information systems (NMI)
Sweden regulates a national product category 'nationella medicinska informationssystem' (NMI, national medical information systems) — products that in terms of use are close to medical devi…
1 source-linked fact
Checked 2026-08-25
Open details →
D04

Classification rules

Verified
EU MDR classes I, Is, Im, Ir, IIa, IIb and III
Class I, Class Is, Class Im, Class Ir, Class IIa, Class IIb, Class III
1 maintained scheme
Checked 2026-08-26
Open details →
D05

Registration pathways

Verified
Check Swedish export-certificate eligibility and the new identity evidence
A Swedish legal manufacturer or Swedish authorised representative for a non EEA manufacturer may request the appropriate free sale certificate when registered as required. The application,…
Check the export certificate against the new identity
For export, the Member State where the manufacturer or authorised representative has its registered place of business shall issue a free sale certificate upon a qualifying request under MDR…
4 source-linked facts
Checked 2026-10-21
Open details →
D06

Reliance & recognition

Verified
NMPA certificate does not replace EU conformity assessment
statement: For ordinary market placement under MDR/IVDR, a Chinese approval does not replace conformity assessment under MDR Article 52 or IVDR Article 48. The applicable EU class and proce…
EU CE under MDR/IVDR — single market validity
target: geo:swe · sourceApproval: EU CE under MDR/IVDR · edgeType: single market validity · marketAccessStrength: direct · regulatoryLayer: product marketing · sameDeviceRequired: Yes · loc…
2 source-linked facts
Checked 2026-09-15
Open details →
D07

Economic-operator roles

Verified
National registration for Art. 16.2-16.4 importers/distributors
Distributors and importers responsible for translation/re labelling or repackaging under MDR/IVDR Art. 16.2 16.4 who sell on the Swedish market must register the activity with Läkemedelsver…
1 source-linked fact
Checked 2026-08-25
Open details →
D08

Establishment, import & distribution

Verified
Distributor/importer duty to inform Läkemedelsverket
Distributors and importers must inform Läkemedelsverket (primarily by e mail to registrator@lakemedelsverket.se) of suspected or confirmed serious risk with a product, suspected or confirme…
1 source-linked fact
Checked 2026-08-25
Open details →
D09

Dossier requirements

Verified
Language of information submitted to the authority
Information and documentation submitted to Läkemedelsverket (e.g. technical documentation provided on request) may be in Swedish or English; the EU declaration of conformity may be in Swedi…
1 source-linked fact
Checked 2026-08-25
Open details →
D10

Official forms & portals

Verified
Official form or portal surface
Läkemedelsverket e services are the national submission channel for registration, change and deregistration of actors/products, for serious incident reports (EU MIR form uploaded in PDF and…
1 source-linked fact
Checked 2026-08-25
Open details →

Submission & evidence

D11

Label, IFU & language

Verified
Keep the responsible manufacturer and device identity consistent
The label identifies the device name or trade name, the manufacturer’s name, registered trade name or trademark and registered business address, and the EU authorised representative where a…
Keep the responsible manufacturer and device identity consistent
The label identifies the device name or trade name, the manufacturer’s name, registered trade name or trademark and registered business address, and the EU authorised representative where a…
5 source-linked facts
Checked 2026-10-21
Open details →
D12

QMS, audit & inspection

Verified
Notified-body QMS certificate required for Art. 16.2-16.4 activities
Importers/distributors performing re labelling/translation or repackaging under MDR/IVDR Art. 16.2 16.4 must have their quality management system verified by a notified body, and must uploa…
1 source-linked fact
Checked 2026-08-25
Open details →
D13

Standards, testing & ancillary approvals

Unresolved
MDR electrical safety in place of the Low Voltage Directive
Electrical safety
MDR electromagnetic compatibility in place of the EMC Directive
EMC
Radioutrustningslagen market access
Wireless / radio
7 maintained overlays
Open details →
D14

Fees

Verified
Annual fee per registered role - manufacturers and authorised representatives
SEK 30,000
Legacy/directive-product company registration
SEK 2,150
9 maintained fee lines · 3 related facts
Checked 2026-08-25
Open details →
D15

Review clocks

Unresolved
Class I · Self-declaration (no notified body)
0 days
1 maintained pathway · 1 related fact
Checked 2026-08-29
Open details →
D16

Approval validity & renewal

Verified
Retain the exact legacy-change and lawful-stock conditions
For eligible legacy IVDs, organisational/name/address/legal form or AR changes are generally not significant design/intended purpose changes under MDCG 2022 6. Apply amended Article 110 rat…
Retain the exact legacy-change and lawful-stock conditions
For eligible legacy MDs, administrative name/address/legal form changes are generally not significant design/intended purpose changes. The merger/acquisition example requires continuation o…
4 source-linked facts
Checked 2026-10-21
Open details →

Lifecycle & post-market

D17

Change control

Verified
Update the actual economic operator and current EUDAMED records
Manufacturers, authorised representatives and importers register their own actor identity in EUDAMED and obtain an SRN where required. Changes to Annex VI Part A actor information are updat…
Document an authorised-representative switch separately
An authorised representative change must be addressed in an agreement between the manufacturer and, where practicable, outgoing and incoming representatives. It covers termination and start…
7 source-linked facts
Checked 2026-10-21
Open details →
D18

UDI, listing & traceability

Verified
Map the actual reference, model and UDI change
A commercial REF, order number or catalogue code must first be mapped to the actual device identifier. Annex VI requires a new UDI DI when a change could cause misidentification or ambiguit…
Map the actual reference, model and UDI change
A commercial REF, order number or catalogue code must first be mapped to the actual device identifier. Annex VI requires a new UDI DI when a change could cause misidentification or ambiguit…
3 source-linked facts
Checked 2026-10-21
Open details →
D19

Clinical investigation & performance

Verified
Fee obligation for clinical investigation applications
A fee must be paid by anyone applying to conduct a clinical investigation of a medical device or a performance study of an IVD with Läkemedelsverket, and by applicants for other device rela…
Application route and mandatory ethics review
Applications and notifications for clinical investigations of devices (MDR) and performance studies of IVDs (IVDR) in Sweden are sent to Läkemedelsverket, which forwards them to Etikprövnin…
2 source-linked facts
Checked 2026-08-25
Open details →
D20

Special access & derogation

Verified
Restrictions on dispens products on the market
A product placed on the market and taken into use under a granted dispens may not be sold or transferred to any care provider/user other than the one stated in the decision; the manufacture…
National dispens from CE requirements or language requirements
Läkemedelsverket may, on application, grant a national exemption (dispens) from conformity assessment/CE marking requirements under MDR Art. 59 / IVDR Art. 54, or from the national Swedish…
2 source-linked facts
Checked 2026-08-25
Open details →
D21

Manufacturer PMS

Verified
Post-market surveillance reporting (Arts. 83-86)
Manufacturers must implement a post market surveillance system (Art. 83) and a documented post market surveillance plan proportionate to the risk class and appropriate to the type of device…
1 source-linked fact
Checked 2026-08-29
Open details →
D22

Vigilance & incident reporting

Verified
Serious incident reporting deadlines
Reporting deadlines from manufacturer awareness: serious public health threat — immediately, at the latest 2 days; death or unexpected serious deterioration of a person's health — immediate…
Manufacturer trend and periodic safety update reporting to LV
Manufacturers report serious incidents, corrective safety actions (FSCA), trends and periodic safety updates (PSR) to Läkemedelsverket as the Swedish competent authority.
3 source-linked facts
Checked 2026-08-25
Open details →
D23

Recall, FSCA & market surveillance

Verified
FSCA and FSN reporting to Läkemedelsverket
FSCAs and FSNs directed at Sweden must be reported to Läkemedelsverket. Manufacturers established in Sweden report to LV regardless of whether the affected products are or were provided in…
1 source-linked fact
Checked 2026-08-25
Open details →
D24

Advertising, claims & promotion

Verified
National sanction fees and penalties for MDR/IVDR violations
Sweden enforces MDR/IVDR obligations nationally: administrative sanction fees (sanktionsavgift) can be imposed inter alia for violations of MDR Art. 7 (misleading claims) or Art. 10 16, up…
1 source-linked fact
Checked 2026-08-25
Open details →
D25

Submission communications & appeal

Verified
Appeal to general administrative court
Decisions under the national act may be appealed to a general administrative court (allmän förvaltningsdomstol); leave to appeal is required for appeal to the administrative court of appeal…
1 source-linked fact
Checked 2026-08-25
Open details →

Government fees

Full fee schedule (9 lines) →

Swedish Medical Products Agency registration fees in SEK · reviewed 2026-08-25

Fee lineAmountProvenance
Annual fee per registered role - manufacturers and authorised representativesSEK 30,000Verified
Legacy/directive-product company registrationSEK 2,150Verified
Legacy/directive-product registration by product countSEK 1,000–10,000Verified
Exemption from conformity assessment (MDR Art. 59 / IVDR Art. 54)SEK 62,000Verified
5 more fee lines on the full schedule · 9 of 9 rows source-verified

Registration timeline

Full registration timeline →

Swedish Medical Products Agency (Swedish Medical Products Agency) review clocks and planning ranges · 4-class (I, IIa, IIb, III) — EU MDR classification

Class / pathwayReview clockPlanning totalProvenance
Class I(Self-declaration (no notified body))

MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock

Elapsed time is Eudamed actor and device registration, which has no guaranteed processing time, plus any national registration duty

0 days6-9 monthsVerified
  1. 1Pre-Submission Preparation(1-3 months)
  2. 2Application Submission(1-2 weeks)
  3. 3Administrative Review(2-4 weeks)
  4. 4Technical Evaluation(0 days)
  5. 5Registration Approval(1-2 weeks)

Latest regulation news

All Sweden regulation news →

Newest official Swedish Medical Products Agency headlines from the daily-refreshed feed — every row links directly to the authority publication.

Sep 17SMSwedish Medical Products AgencyNew Survey: 8 Out of 10 Swedes Do Not Know How to Check the Safety of Medical DevicesSwedenJun 17SMSwedish Medical Products AgencySwedish Medical Products Agency Assumes Responsibility for AI Systems in Medical DevicesSweden
Continue with this market

Turn Sweden research into practical work

The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.

View every AI workpaper →

Build a reusable product master

Structure company, product, model, approval, certificate, and evidence facts before starting Sweden work.

Sweden market-launch workpaper

Connect the Swedish Medical Products Agency route, evidence, labels, local role, timing, and dependencies to a wider launch plan.

Sweden dossier reuse and delta

Compare an existing authorization and evidence set against Swedish Medical Products Agency administrative, testing, labeling, and dossier needs.

Sweden change notification workpaper

Map a product or manufacturing change to Swedish Medical Products Agency evidence, notification, timing, and implementation questions.

Sweden regulatory change impact

Assess a current Swedish Medical Products Agency update against one product and turn it into an owner-ready action workpaper.

Sweden cybersecurity evidence review

Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for Sweden (Swedish Medical Products Agency).

Country hubs in other markets

Other Europe markets

AlbaniaArmeniaAustriaAzerbaijanBelarusBelgiumBosnia and HerzegovinaBulgariaCroatiaCyprusCzech RepublicDenmarkEstoniaEuropean UnionFinlandFranceGeorgiaGermanyGreeceHungaryIcelandIrelandItalyKazakhstanLatviaLiechtensteinLithuaniaLuxembourgMaltaMoldovaMontenegroNetherlandsNorth MacedoniaNorwayPolandPortugalRomaniaRussiaSerbiaSlovakiaSloveniaSpainSwitzerlandTurkeyUkraineUnited KingdomAll 156 markets →
DJ Fang
Entering the Sweden market?
Local representation, Swedish Medical Products Agency submissions, and lifecycle maintenance — handled with an expert.
Pricing